期刊文献+

胸腺肽对严重烧伤患者免疫功能调理的初步研究

Study of immune opsonization by thymic peptide in severe burned patients
在线阅读 下载PDF
导出
摘要 目的研究胸腺肽对严重烧伤患者的免疫调理作用。方法选取30例严重烧伤患者(其中15例除常规治疗外还应用胸腺肽治疗),分别于伤后3、7、14、28天抽取静脉血,酶联免疫吸附实验(ELISA)法测定肿瘤坏死因子-α(TNF-α)、干扰素-γ(IFN-γ),并用流式细胞仪测定单核细胞表面人类白细胞DR抗原(HLA-DR)。结果接受胸腺肽治疗的患者血浆IFN-γ水平升高持续至停药后较长的一段时间,未接受胸腺肽治疗的患者IFN-γ水平几乎测不出。接受胸腺肽治疗的患者与未接受胸腺肽治疗的患者外周血TNF-α水平无显著差异。伤后7、14、28天接受胸腺肽治疗的患者单核细胞HLA-DR较未接受治疗组高。结论胸腺肽对严重烧伤患者的免疫功能有明显改善。 Objective To study the immune opsonization of thymic peptide in severe burned patients. Methods The peripheral blood was drawn from 30 severe burned patients ( 15 of them were given 1.6mg thymic peptide every other day) on days 3,7,14,28 after injury. TNF-α and IFN-7 were measured by means of ELISA. The expressed HLA-DR of monocyte was measured by means of flow cytometry. Results The IFN-7 of the patients who were given thymic peptide increased,which was not found in control group. The TNF-α of the two groups had no significant difference. The HLA-DR in thymic peptide group was higher than that in control group. Conclusion Thymic peptide can largely improve the immune function of severe patients.
出处 《创伤外科杂志》 2009年第4期345-347,共3页 Journal of Traumatic Surgery
关键词 胸腺肽 免疫抑制 抗原 thymic peptide immune inhibition antigen
  • 相关文献

参考文献8

二级参考文献19

  • 1贺石林.多器官衰竭的发病机制[J].中国危重病急救医学,1995,7(6):333-334. 被引量:15
  • 2Wakefeild C H,Carey P D,Foulds S,et al.Changes in major histocom patibility complex class Ⅱ expression in monocytes and T cells of patients developing infection after surgery[J].Br J Surg, 1933.80:205-209.
  • 3Klara A, Windsor A, Boylaston A W, et al.Monocyte activation after open and laparoscopic surgery.Br J Surg[J].1997,84.1152-1156.
  • 4Hershman M J,Cheadle W G,Wellhausen S R,et al.Monocyte HLA-DR antigen expression characterizes clinical outcome in the trauma a patient[J].Br J Surg,1990,77:204-207.
  • 5Volk H D, Reinke P, Krausch D.Moncyte deactivation-rational for a new therapeutic strategy in spesis[J].Intensive Care Med, 1996,22:1-8.
  • 6Ferrer T J,Webb J W, Wallace B H,et al.Interleukin-10 reduces morbidity in MODS[J].J Surg Res,1998,77(20):157-164.
  • 7Pugin J.Sepsis and immune response[J].Intensive Care Med,1999,25(12):1027-1028.
  • 8Volk H D,Reinke P,Docke W D,et al.Clinical aspects:from systemic inflammation to 'immunoparalysis[J].Chem Immunol 2000,74(12):162-177.
  • 9Volk H D,Reinke P,Krausch D.Monocyte deactivation-rational for a new therapeutic strategy in sepsis[J].Intensive Care Med,1996,22(1):1-8.
  • 10Munoz C,Carlet C,Fitting B,et al.Dysfunction of in vitro cytokine production by monocytes during sepsis[J].J Clin Invest,1991,88(10):1747-1758.

共引文献123

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部